• 1
    Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992;304: 8679.
  • 2
    Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal lucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999;13: 2317.
  • 3
    Pandya P. Nuchal translucency thickness. In: NicolaidesKH, SebireNJ, SnijdersJM, editors. The 11–14 Week Scan: The Diagnosis of Fetal Abnormalities. New York: Parthenon; 1999.
  • 4
    The Fetal Medicine Foundation. Downs screening at 11 to 14 weeks. []. Accessed May 2004.
  • 5
    Edwards A, Mulvey S, Wallace EM. The effect of image size on nuchal translucency measurement. Prenat Diagn 2003;23: 2846.
  • 6
    Nicolaides KH, Snijders RJM, Cuckle HS. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 1998;18: 51921.
  • 7
    National Collaborating Centre for Women's and Children's Health. Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press, 2003.